198 related articles for article (PubMed ID: 35257229)
1. Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.
Link H; Kerkmann M; Holtmann L; ;
Support Care Cancer; 2022 Jun; 30(6):5187-5200. PubMed ID: 35257229
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
Visentin A; Molinari MC; Pravato S; Cellini A; Angotzi F; Cavaretta CA; Ruocco V; Imbergamo S; Piazza F; Proietti G; Mauro FR; Trentin L
Curr Oncol; 2022 Dec; 30(1):274-283. PubMed ID: 36661671
[TBL] [Abstract][Full Text] [Related]
3. Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen.
Otremba B; Haslbauer F; Reiser M; Weide R; Obermeier M; Pfründer D
Int J Clin Pharmacol Ther; 2024 Jun; 62(6):241-249. PubMed ID: 38577752
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia.
Freeman JA; Crassini KR; Best OG; Forsyth CJ; Mackinlay NJ; Han P; Stevenson W; Mulligan SP
Leuk Lymphoma; 2013 Jan; 54(1):99-104. PubMed ID: 22738394
[TBL] [Abstract][Full Text] [Related]
5. Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.
Na IK; Buckland M; Agostini C; Edgar JDM; Friman V; Michallet M; Sánchez-Ramón S; Scheibenbogen C; Quinti I
Eur J Haematol; 2019 Jun; 102(6):447-456. PubMed ID: 30801785
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics.
Innocenti I; Tomasso A; Benintende G; Autore F; Fresa A; Vuono F; Stirparo L; Galli E; D'Arena G; Sorà F; Efremov D; Laurenti L
Hematol Oncol; 2022 Aug; 40(3):469-474. PubMed ID: 35076123
[TBL] [Abstract][Full Text] [Related]
7. [Hypogammaglobulinemia and immunodeficiency in multiple myeloma and chronic lymphoid leukemia].
Matthes T; Jandus P
Rev Med Suisse; 2023 Apr; 19(821):668-673. PubMed ID: 37017348
[TBL] [Abstract][Full Text] [Related]
8. A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency.
Benbrahim O; Viallard JF; Choquet S; Royer B; Bauduer F; Decaux O; Crave JC; Fardini Y; Clerson P; Lévy V
Eur J Haematol; 2018 Jul; 101(1):48-56. PubMed ID: 29644723
[TBL] [Abstract][Full Text] [Related]
9. Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia.
Ohmoto A; Fuji S; Shultes KC; Savani BN; Einsele H
Bone Marrow Transplant; 2022 Jun; 57(6):874-880. PubMed ID: 35440805
[TBL] [Abstract][Full Text] [Related]
10. Secondary immunodeficiency in lymphoproliferative malignancies.
Friman V; Winqvist O; Blimark C; Langerbeins P; Chapel H; Dhalla F
Hematol Oncol; 2016 Sep; 34(3):121-32. PubMed ID: 27402426
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
Mustafa SS; Jamshed S; Vadamalai K; Ramsey A
PLoS One; 2021; 16(10):e0258529. PubMed ID: 34653210
[TBL] [Abstract][Full Text] [Related]
12. Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia.
Spaner DE; Venema R; Huang J; Norris P; Lazarus A; Wang G; Shi Y
EBioMedicine; 2018 Sep; 35():222-232. PubMed ID: 30174282
[TBL] [Abstract][Full Text] [Related]
13. Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
Noto A; Cassin R; Mattiello V; Bortolotti M; Reda G; Barcellini W
Front Immunol; 2023; 14():1062376. PubMed ID: 37122737
[TBL] [Abstract][Full Text] [Related]
14. Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study.
Legendre P; Chahwan D; Marjanovic Z; Vignon M; Hermine O; Lortholary O; Morelle G; Darrodes M; Kahn JE; Ouzegdouh M; Chaibi P; Montestruc F; Caumont-Prim A; Le Jouan M; Hassani Y; Godeau B; Durand-Zaleski I; Mouthon L
Clin Immunol; 2020 Jun; 215():108419. PubMed ID: 32289463
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET).
Syed MN; Kutac C; Miller JM; Marsh R; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Kheradmand F; Hajjar J
J Clin Immunol; 2022 Oct; 42(7):1545-1552. PubMed ID: 35779201
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.
Svensson T; Höglund M; Cherif H
Scand J Infect Dis; 2013 Jul; 45(7):537-42. PubMed ID: 23427875
[TBL] [Abstract][Full Text] [Related]
17. Infections in secondary immunodeficiency patients treated with Privigen
Mallick R; Divino V; Smith BD; Jolles S; DeKoven M; Vinh DC
Leuk Lymphoma; 2021 Dec; 62(14):3463-3473. PubMed ID: 34569910
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma.
Giralt S; Jolles S; Kerre T; Lazarus HM; Mustafa SS; Papanicolaou GA; Ria R; Vinh DC; Wingard JR
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):719-732. PubMed ID: 37353432
[TBL] [Abstract][Full Text] [Related]
19. Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy.
Wågström P; Nilsdotter-Augustinsson Å; Nilsson M; Björkander J; Dahle C; Nyström S
Front Immunol; 2021; 12():797336. PubMed ID: 35082787
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry.
Abadeh A; Shehadeh S; Betschel S; Waserman S; Cameron DW; Cowan J
PLoS One; 2023; 18(11):e0294408. PubMed ID: 37971974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]